Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Moleculin Biotech Inc. (MBRX)

0.8557   -0.024 (-2.76%) 07-10 16:00
Open: 0.86 Pre. Close: 0.88
High: 0.88 Low: 0.84
Volume: 713,736 Market Cap: 52M
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (AML) and lung-localized tumors. The company's flagship immune/transcription modulator is WP1066, a STAT3 inhibitor, which is in Phase I clinical trial for the treatment of brain tumor, as well as to treat pancreatic cancer, AML, and glioblastoma. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma in Poland; and WP1732, an analog of WP1066 for the treatment of AML, pancreatic, and other cancers. The company's lead metabolism/glycosylation inhibitor compound is WP1122, a prodrug of 2-deoxyglucose to treat brain tumors and pancreatic cancer. In addition, it develops WP1234 for the treatment of pancreatic cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.882 - 0.887 0.887 - 0.892
Low: 0.826 - 0.832 0.832 - 0.838
Close: 0.85 - 0.859 0.859 - 0.87

Technical analysis

as of: 2020-07-10 4:30:02 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.24     One year: 1.42
Support: Support1: 0.81    Support2: 0.68
Resistance: Resistance1: 1.06    Resistance2: 1.22
Pivot: 0.95
Moving Average: MA(5): 0.88     MA(20): 0.98
MA(100): 0.92     MA(250): 0.99
MACD: MACD(12,26): -0.05     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 22.75     %D(3): 21.43
RSI: RSI(14): 27.65
52-week: High: 1.97  Low: 0.32  Change(%): -29.9
Average Vol(K): 3-Month: 202060  10-Days: 92695

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MBRX has closed above bottom band by 5.4%. Bollinger Bands are 42.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 07 Jul 2020
Is Moleculin Biotech, Inc. (MBRX) a Keeper? Bullish Price Target $5.00 - The News Heater

Tue, 07 Jul 2020
Moleculin Biotech Inc. (NASDAQ:MBRX) is Waving the Bear Flag - The Oracle Dispatch

Thu, 02 Jul 2020
Moleculin Biotech Inc. (MBRX) volume hits 1.06 million: A New Opening for Investors - News Daemon

Wed, 01 Jul 2020
Moleculin Biotech (MBRX) Announces New Publication Finds Combination of WP1066 and Radiation Resulted in Long-Term Survival in Human Brain Tumor Mouse Model - StreetInsider.com

Wed, 01 Jul 2020
Moleculin Biotech, Inc. (MBRX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Fri, 26 Jun 2020
Moleculin Biotech, Inc. (MBRX): Skating on Thin Ice? Beta Stands at 2.40 - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 60
Shares Float (M) 46
% Held by Insiders 11.45
% Held by Institutions 20.38
Shares Short (K) 4,250
Shares Short P. Month (K) 4,040

Stock Financials

EPS -0.226
EPS Est This Year -0.340
EPS Est Next Year -0.360
Book Value (p.s.) 0.290
Profit Margin
Operating Margin
Return on Assets (ttm) -48.2
Return on Equity (ttm) -69.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.295
Qtrly Earnings Growth
Operating Cash Flow (M) -18
Levered Free Cash Flow (M) -14

Stock Valuations

PE Ratio -3.79
PEG Ratio
Price to Book value 2.95
Price to Sales
Price to Cash Flow -2.92

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.